BTA biota holdings limited

"Glaxo shares have gained 21 percent in the past year on demand...

  1. 643 Posts.
    "Glaxo shares have gained 21 percent in the past year on demand for its Relenza flu treatment, the only other drug that's shown promise against bird flu. ``It's a multibillion-dollar market,'' said Bob Pooler, an analyst at Lombard Odier Darier Hentsch & Cie. in Zurich."

    this is a paragraph from the link you posted. i don't understand how this impacts on a company the size of glaxo but the market does not seem to think it has much impact on a much smaller company in biota
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.